These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23548531)

  • 1. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey.
    Sikora JM; Tankersley MS;
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):194-197.e4. PubMed ID: 23548531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception and practice of sublingual immunotherapy among practicing allergists.
    Tucker MH; Tankersley MS;
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey.
    Sivam A; Tankersley M;
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):623-629.e2. PubMed ID: 30946915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
    Tabatabaian F; Casale TB
    Allergy Asthma Proc; 2015; 36(2):100-4. PubMed ID: 25715238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen immunotherapy practice patterns: a worldwide survey.
    Ponda P; Mithani S; Kopyltsova Y; Sison C; Gupta P; Larenas D; Bonagura VR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):454-459.e7. PubMed ID: 22626600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
    Nelson HS; Makatsori M; Calderon MA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual and oral immunotherapy.
    Canonica GW; Compalati E; Fumagalli F; Passalacqua G
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):685-704, vii. PubMed ID: 15474866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual Immunotherapy: Past, present, paradigm for the future? A review of the literature.
    Leatherman BD; Owen S; Parker M; Chadwick S; Fornadley JA; Colson D; Fass P
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3 Suppl):S1-20. PubMed ID: 17321336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L; Jacobsen L
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy.
    Hsu NM; Reisacher WR
    Int Forum Allergy Rhinol; 2012; 2(4):280-4. PubMed ID: 22434716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.